Abnormalities in body composition can occur at any body weight. Low muscle mass is a
predictor of poor morbidity and mortality and occurs in several populations. This narrative …

Background Evidence regarding the association between sarcopenia (skeletal muscle
depletion) and outcomes in patients with lung cancer varies across studies. We aimed to …

Background Computed tomography (CT) analysis of body composition has garnered interest
as a potential prognostic tool in those with cancer. A range of pre‐defined thresholds …

The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …

This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …

Introduction Skeletal muscle depletion, referred to as sarcopenia, has recently been
identified as a risk factor for poor outcomes in various malignancies. However, the …

Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …

Introduction The relationships between morbid obesity, changes in body mass index (BMI)
before cancer diagnosis, and lung cancer outcomes by histology (SCLC and NSCLC) have …

Background Lung cancer is the leading cause of cancer-related mortality worldwide.
Sarcopenia, defined as the loss of muscle mass and function, is known to cause adverse …

Although higher body mass index (BMI) increases the incidence of many cancers, BMI can
also exhibit a null or U-shaped relationship with survival among patients with existing …